Page last updated: 2024-08-16
rolipram and calpain
rolipram has been researched along with calpain in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Arcaro, CA; Assis, RP; Baviera, AM; Brunetti, IL; Kettelhut, IC; Navegantes, LCC; Oliveira, JO; Paula-Gomes, S; Zanon, NM | 1 |
Other Studies
1 other study(ies) available for rolipram and calpain
| Article | Year |
|---|---|
Phosphodiesterase 4 inhibition restrains muscle proteolysis in diabetic rats by activating PKA and EPAC/Akt effectors and inhibiting FoxO factors.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Calpain; Caspase 3; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Diabetes Mellitus, Experimental; Male; Muscle, Skeletal; Muscular Atrophy; Nerve Tissue Proteins; Phosphodiesterase 4 Inhibitors; Phosphorylation; Proteasome Endopeptidase Complex; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Rolipram; Signal Transduction | 2021 |